Gastroesophageal reflux disease: Clinical sciences

Last updated: December 12, 2025

Gastroesophageal reflux disease: Clinical sciences

PL GastroEnteroLG 2460

PL GastroEnteroLG 2460

Appendicitis: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Infectious gastroenteritis: Clinical sciences
Pancreatic cancer: Clinical sciences
Anal cancer: Clinical sciences
Colorectal cancer screening: Clinical sciences
Colorectal cancer: Clinical sciences
Esophageal cancer: Clinical sciences
Gastric cancer: Clinical sciences
Short bowel syndrome: Clinical sciences
Approach to diarrhea (chronic): Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Approach to constipation: Clinical sciences
Esophagitis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Gastroesophageal varices: Clinical sciences
Mallory-Weiss syndrome: Clinical sciences
Medication-induced constipation: Clinical sciences
Approach to biliary colic: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Diverticulitis: Clinical sciences
Pilonidal disease: Clinical sciences
Hemorrhoids: Clinical sciences
Anal fissure: Clinical sciences
Fecal impaction: Clinical sciences
Approach to perianal problems: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Chronic mesenteric ischemia: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Cirrhosis: Clinical sciences
Acute pancreatitis: Clinical sciences
Chronic pancreatitis: Clinical sciences
Approach to ascites: Clinical sciences
Colonic volvulus: Clinical sciences
Ileus: Clinical sciences
Intussusception: Clinical sciences
Ischemic colitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Necrotizing enterocolitis: Clinical sciences
Small bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Stress ulcers: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Intra-abdominal abscess: Clinical sciences
Spontaneous bacterial peritonitis: Clinical sciences
Approach to hepatic masses: Clinical sciences
Approach to pancreatic masses: Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Approach to hematochezia: Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Approach to melena and hematemesis: Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to penetrating neck injury: Clinical sciences
Esophageal perforation: Clinical sciences
Femoral hernias: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Inguinal hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Ventral and incisional hernias: Clinical sciences
Pyloric stenosis: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Gastroesophageal reflux disease, or GERD for short, is a chronic condition in which the lower esophageal sphincter becomes weak or relaxes at the wrong time. This allows acidic content from the stomach to flow back up into the esophagus. Over time, exposure to gastric acid can irritate and damage the lining of the esophagus and cause a variety of symptoms, which are commonly grouped into typical, atypical, and alarm symptoms.

Now, if your patient presents with signs and symptoms suggestive of GERD, you should first perform an ABCDE assessment to determine if your patient is unstable or stable.

If unstable, stabilize their airway, breathing, and circulation. Next, obtain IV access and administer IV fluids, and don’t forget to put your patient on continuous vital sign monitoring. Finally, if you identify signs of active gastrointestinal bleeding, such as melena or hematemesis, perform an emergent esophagogastroduodenoscopy, or EGD.

Now, let’s go back and take a look at stable patients.

In this case, start with a focused history and physical examination. Individuals with GERD might report classic symptoms, like heartburn, also known as pyrosis, acid regurgitation, or a sour or bitter taste in the back of the mouth.

Some might also experience non-specific symptoms, such as chronic cough, hoarseness, or frequent throat clearing.

On physical exam, findings are usually normal. However, in some cases, you might notice subtle signs of acid damage, such as dental erosion. If your patient reports any of these symptoms, suspect GERD.

Next, assess the patient for alarm signs and symptoms that warrant urgent evaluation for GERD complications. These include anemia, dysphagia or odynophagia, gastrointestinal bleeding, frequent vomiting, or unintentional weight loss.

If one or more alarm signs and symptoms are present, you should suspect a GERD complication and proceed with an urgent EGD with biopsies.

If the biopsy reveals friable, erythematous epithelium with inflammatory cells consistent with erosive esophagitis, the diagnosis is GERD.

Management of course includes lifestyle modifications, such as smoking cessation, and reducing foods that trigger reflux symptoms, such as tomatoes and alcohol.

However, the cornerstone of treatment is acid suppression, which typically involves proton pump inhibitors, or PPIs, such as omeprazole, and histamine-2 receptor antagonists, or H2-blockers, such as famotidine. Although both PPIs and H2-blockers reduce acid secretion, PPIs are the primary treatment because they relieve symptoms more effectively and promote better healing of esophageal damage than H2-blockers.

Now, here’s a clinical pearl to keep in mind! For intermittent symptom relief, you can also opt for antacids, such as magnesium hydroxide, which work by neutralizing stomach acid.

On the flip side, sucralfate, a nonabsorbable mucosal protective agent, is not commonly used in GERD treatment outside of special situations.

Finally, if your patient experiences recurrent symptoms or you need to evaluate the healing of the esophageal lining, consider repeating an EGD.

Now, let’s go back to EGD and biopsy because in some individuals, erosive esophagitis can progress to more serious conditions.

During the procedure, you might detect an esophageal mass or stricture, while a biopsy might reveal columnar metaplasia or dysplasia, a finding known as Barrett esophagus.

All these findings are suggestive of chronic GERD complications.

In these individuals, again, encourage lifestyle modifications and initiate medical therapy with PPIs or H2-blockers. Additional treatment options include endoscopic interventions, like esophageal dilation to reduce stricture, and endoscopic ablation for dysplasia. Sometimes, you will have to consult your surgical team for esophageal resection of a mass.

Finally, in individuals with Barrett esophagus, repeated EGDs are essential to monitor the esophageal mucosa, because metaplasia can progress to dysplasia, which is a precancerous stage, and eventually to esophageal adenocarcinoma.

Now that we’ve covered how to approach individuals with alarm signs and symptoms, let’s take a step back and look at what to do when these features are absent.

In this case, your first step is to assess the type of GERD presentation.

Now, if your patient reports typical GERD symptoms, such as heartburn, acid regurgitation, or sour or bitter taste in the mouth, and their physical examination is normal, suspect GERD with typical features.

But sometimes, a person may report both typical and atypical GERD symptoms. Atypical symptoms can include chronic cough, hoarseness, frequent throat clearing, laryngitis, pharyngitis, or even sinusitis.

On physical exam, you might find wheezing or signs of acid regurgitation in the mouth, such as dental erosions or erythema. In this case, you should suspect GERD with both typical and atypical features.

In both groups, treatment starts with lifestyle modifications and an eight-week trial of PPIs. After eight weeks, assess the patient’s response to treatment.

If symptoms show an adequate response, diagnose GERD and continue encouraging lifestyle changes, while closely monitoring for any recurrence.

On the other hand, if there’s an inadequate response, or in other words, if symptoms persist during the trial or return after it ends, proceed with an EGD and biopsy.

Sources

  1. "ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease" Am J Gastroenterol (2022)
  2. "AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review" Clin Gastroenterol Hepatol (2022)
  3. "How to Interpret Esophageal Impedance pH Monitoring" J Neurogastroenterol Motil (2010)
  4. "Diseases of the Esophagus" Goldman-Cecil Medicine, 26th ed. (2020)
  5. "Gastroesophageal Reflux Disease" CDIM CORE MEDICINE CLERKSHIP CURRICULUM GUIDE, 4TH EDITION (2020)
  6. "Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now?" Clin Gastroenterol Hepatol (2018)
  7. "Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. " Am J Gastroenterol. (2022 Apr 1;117(4):559-587. )